These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 34000263)
21. Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma. Wu SY; Liao P; Yan LY; Zhao QY; Xie ZY; Dong J; Sun HT BMC Gastroenterol; 2021 Nov; 21(1):416. PubMed ID: 34724892 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis. Han X; Long W; Liu Y; Xu J Front Surg; 2022; 9():985034. PubMed ID: 36338652 [TBL] [Abstract][Full Text] [Related]
23. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy. Yang Q; Zeng S; Liu W PeerJ; 2023; 11():e15019. PubMed ID: 36949759 [TBL] [Abstract][Full Text] [Related]
24. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors. Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B PeerJ; 2022; 10():e14432. PubMed ID: 36518297 [TBL] [Abstract][Full Text] [Related]
25. Scinderin is a potential prognostic biomarker and correlated with immunological regulation: from pan-cancer analysis to liver hepatocellular carcinoma. Zhai S; Li Y; Yang Y; Lang W; Liu X; Liu K; Qu J; Zhu L Front Immunol; 2024; 15():1361657. PubMed ID: 39108273 [TBL] [Abstract][Full Text] [Related]
26. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma. Wang Z; Chen S; Wang G; Li S; Qin X Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380 [TBL] [Abstract][Full Text] [Related]
27. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma. Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200 [TBL] [Abstract][Full Text] [Related]
28. BUB1 predicts poor prognosis and immune status in liver hepatocellular carcinoma. Qi W; Bai Y; Wang Y; Liu L; Zhang Y; Yu Y; Chen H APMIS; 2022 Jul; 130(7):371-382. PubMed ID: 35255180 [TBL] [Abstract][Full Text] [Related]
29. Regulator of nonsense transcripts 3B is a prognostic biomarker and associated with immune cell infiltration in lung squamous cell and hepatocellular carcinoma. Li P; Zhou M; Gan X; Yuan C; Li G; Jin GN; Ding ZY Discov Oncol; 2024 Sep; 15(1):479. PubMed ID: 39331207 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer. Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148 [TBL] [Abstract][Full Text] [Related]
31. Protein Regulator of Cytokinesis 1 (PRC1) Upregulation Promotes Immune Suppression in Liver Hepatocellular Carcinoma. Zhang C; Xu H; Sui X; Wu T; Chen B; Wang S; Wang X J Immunol Res; 2022; 2022():7073472. PubMed ID: 35983074 [TBL] [Abstract][Full Text] [Related]
32. Landscape of associations between long non-coding RNAs and infiltrating immune cells in liver hepatocellular carcinoma. Li L; Song X; Lv Y; Jiang Q; Fan C; Huang D J Cell Mol Med; 2020 Oct; 24(19):11243-11253. PubMed ID: 32910548 [TBL] [Abstract][Full Text] [Related]
33. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma. Pei W; Jiang M; Liu H; Song J; Hu J Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890 [TBL] [Abstract][Full Text] [Related]
34. A Novel Oncogenic Role of Disulfidptosis-related Gene SLC7A11 in Anti-tumor Immunotherapy Response to Human Cancers. Xu B; Liang J; Fu L; Wei J; Lin J Curr Cancer Drug Targets; 2024; 24(8):846-866. PubMed ID: 38303526 [TBL] [Abstract][Full Text] [Related]
35. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma. Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688 [TBL] [Abstract][Full Text] [Related]
36. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma. Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863 [TBL] [Abstract][Full Text] [Related]
37. Exploration of YBX1 role in the prognostic value and immune characteristics by single-cell and bulk sequencing analysis for liver hepatocellular carcinoma. Zhang Q; Zhu B; Yang H; Li F; Qu Y; Lu L; Zhang Q J Gene Med; 2024 Mar; 26(3):e3680. PubMed ID: 38448368 [TBL] [Abstract][Full Text] [Related]
38. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma. Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158 [No Abstract] [Full Text] [Related]
39. Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker. Wang Y; Liu T; Zhang K; Huang RH; Jiang L Eur J Med Res; 2023 Jul; 28(1):258. PubMed ID: 37501187 [TBL] [Abstract][Full Text] [Related]
40. Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma. Han J; Wang Y; Zhou H; Ai S; Wan D Comput Math Methods Med; 2022; 2022():6267851. PubMed ID: 36238495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]